Y. Chen, C. Hu, and Y. Wang. Biostatistics (Oxford, England), 7 (4):
515-29(October 2006)5077<m:linebreak></m:linebreak>JID: 100897327; 2006/02/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
R. Chappell. Clinical cancer research : an official journal of the American Association for Cancer Research, 18 (8):
2127-9(April 2012)6822<m:linebreak></m:linebreak>CI: (c)2012; JID: 9502500; CON: Clin Cancer Res. 2012 Apr 15;18(8):2301-8. PMID: 22282466; 2012/03/16 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
P. Silcocks. Journal of epidemiology and community health, 63 (10):
856-61(October 2009)5278<m:linebreak></m:linebreak>JID: 7909766; aheadofprint;<m:linebreak></m:linebreak>Anàlisi de supervivència.
V. Stel, F. Dekker, G. Tripepi, C. Zoccali, and K. Jager. Nephron. Clinical practice, 119 (3):
c255-60(January 2011)6596<m:linebreak></m:linebreak>CI: Copyright (c) 2011; JID: 101159763; 2011/09/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Introductori; Nefrologia.
J. Robins, M. Hernán, and A. Rotnitzky. American journal of epidemiology, 166 (9):
994-1002; discussion 1003-4(November 2007)4950<m:linebreak></m:linebreak>GR: R01-HL080644/HL/NHLBI NIH HHS/United States; GR: R37-AI032475/AI/NIAID NIH HHS/United States; JID: 7910653; CON: Am J Epidemiol. 2007 Nov 1;166(9):985-93. PMID: 17875580; 2007/09/17 aheadofprint; ppublish;.
H. Mannan, and J. McNeil. Journal of evaluation in clinical practice, 19 (2):
358-62(April 2013)6705<br/>CI: (c) 2012; JID: 9609066; aheadofprint;<br/>Models predictius; Avaluació de riscs; CV; SAS; Software estadístic.
E. Vittinghoff, and C. McCulloch. American journal of epidemiology, 165 (6):
710-8(March 2007)4832<m:linebreak></m:linebreak>JID: 7910653; 2006/12/20 aheadofprint; ppublish;.
S. Natarajan, S. Lipsitz, and E. Rimm. Statistics in medicine, 26 (17):
3229-39(July 2007)7560<m:linebreak></m:linebreak>JID: 8215016; ppublish;<m:linebreak></m:linebreak>Risc atribuïble; Límits de confiança; Online.
J. Llorca, and M. Delgado-Rodríguez. Gaceta sanitaria / S.E.S.P.A.S, 13 (5):
399-406(1999)2901<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
L. Chen, M. Yen, H. Wu, C. Liao, D. Liou, H. Kuo, and T. Chen. Journal of evaluation in clinical practice, 11 (2):
181-93(April 2005)3816<m:linebreak></m:linebreak>Anàlisi de supervivència; SAS.
S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
B. Langholz, and D. Richardson. American journal of epidemiology, 171 (3):
377-83(February 2010)5491<m:linebreak></m:linebreak>JID: 7910653; aheadofprint;.
C. Lamina, G. Sturm, B. Kollerits, and F. Kronenberg. Journal of clinical epidemiology, 65 (8):
855-62(August 2012)6747<m:linebreak></m:linebreak>CI: Copyright (c) 2012; JID: 8801383; 2011/09/27 received; 2012/02/08 revised; 2012/02/15 accepted; 2012/05/30 aheadofprint; ppublish;<m:linebreak></m:linebreak>Presentació de dades; Anàlisi de dades; Interacció; R; Anàlisi de supervivència; GLM.
O. Naggara, J. Raymond, F. Guilbert, D. Roy, A. Weill, and D. Altman. AJNR. American journal of neuroradiology, 32 (3):
437-40(March 2011)6281<m:linebreak></m:linebreak>ClinicalTrials.gov/NCT00537134; GR: Canadian Institutes of Health Research/Canada; JID: 8003708; 2011/02/17 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Categorització.
S. Samuelsen, and G. Eide. Statistics in medicine, 27 (9):
1447-67(April 2008)4992<m:linebreak></m:linebreak>CI: 2008; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
H. Kim. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (2 Pt 1):
559-65(January 2007)4698<m:linebreak></m:linebreak>LR: 20071203; GR: AI 029530/AI/NIAID NIH HHS/United States; GR: HL 070149/HL/NHLBI NIH HHS/United States; JID: 9502500; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
B. Miladinovic, A. Kumar, R. Mhaskar, S. Kim, R. Schonwetter, and B. Djulbegovic. PloS one, 7 (10):
e47804(January 2012)6965<m:linebreak></m:linebreak>JID: 101285081; 2012/05/11 received; 2012/09/21 accepted; 2012/10/17 epublish; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Avaluació de riscs.
K. Leffondré, K. Jager, J. Boucquemont, V. Stel, and G. Heinze. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 29 (10):
1806-14(October 2014)Anàlisi de dades; Nefrologia; Introductori.
B. George, S. Seals, and I. Aban. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 21 (4):
686-94(August 2014)Anàlisi de supervivència; Introductori; SAS.
R. van Domburg, S. Hoeks, I. Kardys, M. Lenzen, and E. Boersma. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 9 (12):
1472-3(January 2014)Anàlisi de dades; Sample size; Regressió logística; Anàlisi de supervivència.